跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nephromin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nephromin
Approved
STANDARD
Nephromin
Stallion Laboratiries Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4cab331b8d79aeda
Company
Stallion Laboratiries Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
4cab331b8d79aeda
Drug Approval Philippines Name
Nephromin
Product Name
Nephromin
Registration Number
DRP-6051-11
Brand Name
Nephromin
Generic Name
Ketoanalogues + Essential Amino Acids
Dosage Form
Film-Coated Tablet
Dosage Strength
101mg/86mg/68mg/67mg/59mg/105mg/53mg/38mg/30mg/23mg
Manufacturer
Stallion Laboratiries Pvt. Ltd.
Importer
Ambica International Trading Corp.
Distributor
Caledan Pharma Corp.
Issuance Date
25 July 2024
Expiry Date
13 March 2030
Pharmacologic Category
Renal Nutrition Therapy
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4cab331b8d79aeda
Type
Standard
Back to Philippines FDA Approvals